PolyActiva has received funding from private capital investors and been a recipient of a number of grant programs
The Medical Research Commercialisation Fund (MRCF) was established in 2007 as an innovative investment collaboration. The MRCF invests in early stage development and commercialisation opportunities emanating from Australian medical research institutes and allied research hospitals. The MRCF was founded through collaboration between Australia's leading medical research institutes and Statewide and Westscheme Superannuation funds, with support from the State Governments of Victoria, New South Wales, Western Australia and Queensland. The MRCF is an evergreen fund that is managed by Brandon Capital Partners, an experienced life science fund manager.
About Yuuwa Capital LP
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia.
Yuua invests in outstanding opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors build great companies. Yuuwa invests in early stage companies principally in the areas of Life Sciences and Information and Communications Technology. Yuuwa Capital's formation in 2009 was supported by private investors who work with Candor Financial Management and also by the Australian Federal Government's Innovation Investment Fund program.
As of 30 June 2012, PolyActiva had secured more than $500,000 of grant funding from the following sources:
|NHMRC Development Grant||Ocular Implant for the Treatment of Bacterial Endophthalmitis|
|Commercialisation Australia POC Grant||Establish and Prove the Efficient Manufacture and Performance of Novel Drug Candidate Conjugate Releasing Erodible Polymer Fibres that can be used in Woundcare Products|
|STIUP STTech Grant||Synthesis of Drug-Monomers|
|STIUP STFeas Grant||Novel Diisocyanates|
In addition, PolyActiva is the sole industry partner in a $240,000 ARC linkage grant with Monash University and Melbourne University.